Topics » Migraine and Headache
Migraine and Headache
Featured Article Matthew Robbins, MD, author of “COVID-19 and headache: a primer for trainees,” details how care has changed for patients with chronic headaches in the midst of the COVID-19 pandemic.
Latest News The heterogeneous expression of headache associated with COVID-19 indicates various underlying pathophysiological mechanisms.
The ADVANCE study included 910 adults who experienced 4 to 14 migraines per month.
Serum allopregnanolone levels are lower in women with either menstrually related or postmenopausal migraine compared with women without headache.
Acute sleep deprivation may cause increased frequency of cortical spreading depolarization and reduce its electrical threshold.
Compared with healthy control participants, pediatric patients with chronic migraine reported a higher rate of depression.
Approximately one-third of patients with migraine reported using opioids to treat their symptoms, a practice that contrasts with current guidelines.
Mechanical pain thresholds may be used to predict the next headache attack in patients with migraine.
The bidirectional relationship between migraine and sleep disorders are examined in this article.
Positive results were announced from the phase 3 STOP-301 study evaluating INP104 (intranasal dihydroergotamine mesylate; Impel NeuroPharma) for the treatment of acute migraine in adults.
The investigators observed greater brain activations in the frontal regions associated with cognitive regulation of pain after CBT.
Load More
Want to read more?
Please login or register first to view this content.
Login
Register
Open
Next post in Migraine and Headache
Close
